CN101199818A - A pharmaceutical composition for treating calculus - Google Patents
A pharmaceutical composition for treating calculus Download PDFInfo
- Publication number
- CN101199818A CN101199818A CNA2007101124798A CN200710112479A CN101199818A CN 101199818 A CN101199818 A CN 101199818A CN A2007101124798 A CNA2007101124798 A CN A2007101124798A CN 200710112479 A CN200710112479 A CN 200710112479A CN 101199818 A CN101199818 A CN 101199818A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- weight
- herba
- portions
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 32
- 239000000454 talc Substances 0.000 claims abstract description 11
- 229910052623 talc Inorganic materials 0.000 claims abstract description 11
- 239000002552 dosage form Substances 0.000 claims abstract description 4
- 210000000582 semen Anatomy 0.000 claims description 32
- 239000003814 drug Substances 0.000 claims description 27
- 241000566693 Asteriscus Species 0.000 claims description 16
- 241000903946 Clematidis Species 0.000 claims description 16
- 241000218176 Corydalis Species 0.000 claims description 16
- 241000628997 Flos Species 0.000 claims description 16
- 241000237903 Hirudo Species 0.000 claims description 16
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 16
- 241000180649 Panax notoginseng Species 0.000 claims description 16
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 16
- 241000255626 Tabanus <genus> Species 0.000 claims description 16
- 210000003038 endothelium Anatomy 0.000 claims description 16
- 235000012222 talc Nutrition 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 12
- 208000000913 Kidney Calculi Diseases 0.000 claims description 6
- 206010029148 Nephrolithiasis Diseases 0.000 claims description 6
- 241001529553 Scoparia <angiosperm> Species 0.000 claims description 6
- 201000001883 cholelithiasis Diseases 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 208000031868 Calculus ureteric Diseases 0.000 claims description 4
- 208000000014 Ureteral Calculi Diseases 0.000 claims description 4
- 206010004637 Bile duct stone Diseases 0.000 claims description 3
- 201000009331 Choledocholithiasis Diseases 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000006196 drop Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000008176 lyophilized powder Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 4
- 210000000232 gallbladder Anatomy 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 2
- 241000218158 Clematis Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 208000015924 Lithiasis Diseases 0.000 abstract 1
- 241000612166 Lysimachia Species 0.000 abstract 1
- 241000025505 Pyrrosia Species 0.000 abstract 1
- 238000013532 laser treatment Methods 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 description 14
- 238000002604 ultrasonography Methods 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 239000002131 composite material Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000000941 bile Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 2
- 206010061695 Biliary tract infection Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000002330 Congenital Heart Defects Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 208000028831 congenital heart disease Diseases 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a pharmaceutical composition for treating calculi. Is prepared from 30 Chinese-medicinal materials including lysimachia, clematis root, ox horn, chicken's gizzard-skin, pyrrosia leaf, talc, etc. The pharmaceutical composition of the invention is prepared into any clinically acceptable dosage form by adding conventional auxiliary materials according to the conventional process. The pharmaceutical composition has the effects of clearing heat, benefiting gallbladder, dissolving and dissolving calculus, removing calculus and the like, does not need surgery or laser treatment for treating lithiasis, and has remarkable curative effect.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of pharmaceutical composition for the treatment of calculus.
Background technology
Calculus is a kind of commonly encountered diseases, frequently-occurring disease.Its cause of disease complexity, cholelithiasis mostly is the bile pool and slips, the change of bile physical and chemical composition, and biliary tract infection, the liver and gall vein obstruction and do not expand due to, it is too high and precipitation (as calcium, salt etc.) occurs that urinary system calculus mostly is blood mineral composition, or some physically different factor causes crystalline solid to form.Western medical treatment is with surgical calculus removing or laser lithotripsy, and the cholelithiasis doctor trained in Western medicine is to take gallbladder removal at present, has brought misery and sequela to the patient, and this method of treatment expense height is painful big, and easily repeatedly, the patient is difficult to accept.
Summary of the invention
The object of the invention is to provide a kind of pharmaceutical composition for the treatment of calculus.
Another purpose of the present invention is to provide the new purposes of this pharmaceutical composition.
The present invention is achieved through the following technical solutions:
The crude drug of pharmaceutical composition of the present invention consists of:
Herba Lysimachiae 6-20 weight portion Radix Clematidis 6-20 weight portion Cornu Bovis seu Bubali silk 6-20 weight portion
Endothelium Corneum Gigeriae Galli 2-6 weight portion Folium Pyrrosiae 2-8 weight portion Talcum 4-12 weight portion
Mirabilitum 2-6 weight portion Pumex 3-9 weight portion HUOXUEDAN 6-20 weight portion
Asteriscus Pseudosciaenae 2-6 weight portion Semen Abutili 4-12 weight portion Sal Nitri 2-6 weight portion
Semen Plantaginis 2-6 weight portion Spora Lygodii 2-8 weight portion Poria 2-6 weight portion
Flos Lonicerae 2-6 weight portion Herba Taraxaci 4-12 weight portion Radix Et Rhizoma Rhei 1-2 weight portion
Radix Notoginseng 2-6 weight portion Rhizoma Corydalis 2-6 weight portion Herba Artemisiae Scopariae 4-12 weight portion
Radix Curcumae 2-6 weight portion Herba Camptosori Sibirici 4-12 weight portion Hirudo 0.5-1.5 weight portion
Tabanus 0.5-1.5 weight portion Herba Polygoni Avicularis 2-6 weight portion Herba Dianthi 2-6 weight portion
Rhizoma Coptidis 1.5-4.5 weight portion Herba clerodendranthi spicati 4-12 weight portion Radix Salviae Miltiorrhizae 2-8 weight portion
The crude drug composition of pharmaceutical composition of the present invention is preferably
Herba Lysimachiae 13 weight portion Radix Clematidis 13 weight portion Cornu Bovis seu Bubali silk 13 weight portions
Endothelium Corneum Gigeriae Galli 4 weight portion Folium Pyrrosiae 5 weight portion Talcums 8 weight portions
Mirabilitum 4 weight portion Pumexs 6 weight portion HUOXUEDAN 13 weight portions
Asteriscus Pseudosciaenae 4 weight portion Semen Abutilis 8 weight portion Sal Nitri 4 weight portions
Semen Plantaginis 4 weight portion Spora Lygodii 5 weight portion Porias 4 weight portions
Flos Lonicerae 4 weight portion Herba Taraxacis 8 weight portion Radix Et Rhizoma Rhei 1.5 weight portions
Radix Notoginseng 4 weight portion Rhizoma Corydalis 4 weight portion Herba Artemisiae Scopariaes 8 weight portions
Radix Curcumae 4 weight portion Herba Camptosori Sibiricis 8 weight portion Hirudos 1 weight portion
Tabanus 1 weight portion Herba Polygoni Avicularis 4 weight portion Herba Dianthis 4 weight portions
Rhizoma Coptidis 3 weight portion Herba clerodendranthi spicati 8 weight portion Radix Salviae Miltiorrhizaes 5 weight portions
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Herba Lysimachiae 8 weight portion Radix Clematidis 18 weight portion Cornu Bovis seu Bubali silk 8 weight portions
Endothelium Corneum Gigeriae Galli 5 weight portion Folium Pyrrosiae 3 weight portion Talcums 10 weight portions
Mirabilitum 3 weight portion Pumexs 8 weight portion HUOXUEDAN 8 weight portions
Asteriscus Pseudosciaenae 5 weight portion Semen Abutilis 6 weight portion Sal Nitri 5 weight portions
Semen Plantaginis 3 weight portion Spora Lygodii 6 weight portion Porias 3 weight portions
Flos Lonicerae 5 weight portion Herba Taraxacis 6 weight portion Radix Et Rhizoma Rhei 1.8 weight portions
Radix Notoginseng 3 weight portion Rhizoma Corydalis 5 weight portion Herba Artemisiae Scopariaes 6 weight portions
Radix Curcumae 5 weight portion Herba Camptosori Sibiricis 6 weight portion Hirudos 1.2 weight portions
Tabanus 0.7 weight portion Herba Polygoni Avicularis 5 weight portion Herba Dianthis 3 weight portions
Rhizoma Coptidis 4 weight portion Herba clerodendranthi spicati 10 weight portion Radix Salviae Miltiorrhizaes 3 weight portions
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Herba Lysimachiae 18 weight portion Radix Clematidis 8 weight portion Cornu Bovis seu Bubali silk 18 weight portions
Endothelium Corneum Gigeriae Galli 3 weight portion Folium Pyrrosiae 7 weight portion Talcums 6 weight portions
Mirabilitum 5 weight portion Pumexs 4 weight portion HUOXUEDAN 18 weight portions
Asteriscus Pseudosciaenae 3 weight portion Semen Abutilis 10 weight portion Sal Nitri 3 weight portions
Semen Plantaginis 5 weight portion Spora Lygodii 3 weight portion Porias 5 weight portions
Flos Lonicerae 3 weight portion Herba Taraxacis 10 weight portion Radix Et Rhizoma Rhei 1.2 weight portions
Radix Notoginseng 5 weight portion Rhizoma Corydalis 3 weight portion Herba Artemisiae Scopariaes 10 weight portions
Radix Curcumae 3 weight portion Herba Camptosori Sibiricis 10 weight portion Hirudos 0.7 weight portion
Tabanus 1.2 weight portion Herba Polygoni Avicularis 3 weight portion Herba Dianthis 5 weight portions
Rhizoma Coptidis 2 weight portion Herba clerodendranthi spicati 10 weight portion Radix Salviae Miltiorrhizaes 3 weight portions
Pharmaceutical composition of the present invention adds the dosage form that conventional adjuvant is made clinical acceptance by practice of pharmacy, as tablet, capsule, granule, pill, powder, decoction, oral liquid, lyophilized powder or drop pill etc.
Pharmaceutical composition of the present invention has effects such as clearing heat secreting bile, fossil lithodialysis, calculus, need not perform the operation or laser therapy to the treatment calculus, and evident in efficacy.
Following experimental example and embodiment are used to further specify the present invention, but are not limited to the present invention.
Experimental example 1
Medicine composite for curing renal calculus 31 examples of the present invention obtain remarkable result, now are reported as follows:
1, clinical data
Pharmaceutical composition clinical observation renal calculus patient 31 examples of the present invention, male's 15 examples, women's 16 examples; Age 16-50 year 22 examples, 9 examples more than 50 years old.
2, diagnostic criteria
31 routine patients all confirm to suffer from renal calculus through ultrasound diagnosis.
3, Therapeutic Method
3.1 medicine is formed: Herba Lysimachiae 13g, Radix Clematidis 13g, Cornu Bovis seu Bubali silk 13g, Endothelium Corneum Gigeriae Galli 4g, Folium Pyrrosiae 5g, Talcum 8g, Mirabilitum 4g, Pumex 6g, HUOXUEDAN 13g, Asteriscus Pseudosciaenae 4g, Semen Abutili 8g, Sal Nitri 4g, Semen Plantaginis 4g, Spora Lygodii 5g, Poria 4g, Flos Lonicerae 4g, Herba Taraxaci 8g, Radix Et Rhizoma Rhei 1.5g Radix Notoginseng 4g, Rhizoma Corydalis 4g, Herba Artemisiae Scopariae 8g, Radix Curcumae 4g, Herba Camptosori Sibirici 8g, Hirudo 1g, Tabanus 1g, Herba Polygoni Avicularis 4g, Herba Dianthi 4g, Rhizoma Coptidis 3g, Herba clerodendranthi spicati 8g, Radix Salviae Miltiorrhizae 5g.
3.2 instructions of taking: said medicine technology is routinely made decoction, per two days potions.
4, treatment standard
Recovery from illness: confirm not see calculus through ultrasound diagnosis;
Take a turn for the better: calculus part contracted position moves down;
Invalid: with indistinction before the treatment.
5, therapeutic outcome
Do not see 30 examples that have of calculus through ultrasound diagnosis, calculus obviously reduces 1 example, and treatment time is the shortest 5 days, and is the longest 28 days, and cure rate is 97%, and total effective rate is 100%.
6, model case
The week * *, the man, 38 years old, suffer from renal calculus, on May 1st, 2002 came here to seek medical advice, and readme calendar year 2001 is checked left kidney 0.8cm, right kidney 1cm at county hospital, diagnosis: renal calculus, and show B ultrasonic and confirm is invalid through certain county people's hospital's treatment and laser lithotripsy 5 times.When by the agency of came here cure to go to a doctor: acute face dolorosa, urine line were thin, dysurea, yellowish urine companion percussion tenderness over kidney region, look its B ultrasonic report and give secret recipe fossil capsule of the present invention, in May 16 through the check of county hospital B ultrasonic, do not see calculus, follow up a case by regular visits to so far, recurrence.
Experimental example 2
Medicine composite for curing cholelithiasis 16 examples of the present invention obtain remarkable result, now are reported as follows:
1, clinical data
Pharmaceutical composition clinical observation gallstone patients 16 examples of the present invention, male's 9 examples, women's 8 examples; Age 16-50 year 10 examples, 6 examples more than 50 years old.
2, diagnostic criteria
16 routine patients all confirm to suffer from cholelithiasis through ultrasound diagnosis.
3, Therapeutic Method
3.1 medicine is formed: Herba Lysimachiae 8g, Radix Clematidis 18g, Cornu Bovis seu Bubali silk 8g, Endothelium Corneum Gigeriae Galli 5g, Folium Pyrrosiae 3g, Talcum 10g, Mirabilitum 3g, Pumex 8g, HUOXUEDAN 8g, Asteriscus Pseudosciaenae 5g, Semen Abutili 6g, Sal Nitri 5g, Semen Plantaginis 3g, Spora Lygodii 6g, Poria 3g, Flos Lonicerae 5g, Herba Taraxaci 6g, Radix Et Rhizoma Rhei 1.8g, Radix Notoginseng 3g, Rhizoma Corydalis 5g, Herba Artemisiae Scopariae 6g, Radix Curcumae 5g, Herba Camptosori Sibirici 6g, Hirudo 1.2g, Tabanus 0.7g, Herba Polygoni Avicularis 5g, Herba Dianthi 3g, Rhizoma Coptidis 4g, Herba clerodendranthi spicati 10g, Radix Salviae Miltiorrhizae 3g.
3.2 instructions of taking: said medicine technology is routinely made powder, every day 3 times, each 18 grams.
4, treatment standard
Recovery from illness: confirm not see calculus through ultrasound diagnosis;
Take a turn for the better: calculus part contracted position moves down;
Invalid: with indistinction before the treatment.
5, therapeutic outcome
16 routine patients there is no calculus through ultrasound diagnosis, and treatment time is the shortest 5 days, and are the longest 28 days, and cure rate is 100%.
6, model case
Case 1 sieve * *, the woman, 60 years old, suffer from cholelithiasis, in July, 2005 seeks medical advice in here, and readme is at the about 0.5cm of certain county institute of traditional Chinese medicine ultrasound diagnosis gallbladder wall thickness, and visible a plurality of strong echo light 2.3 * 0.8cm of group diagnose: Biliary calculus with cholecystitis in the capsule.And show the B ultrasonic confirmation, and congenital heart disease being arranged, can't perform the operation.By the agency of comes here to cure, and gives secret recipe fossil capsule of the present invention, and in JIUYUE, 2005 inspection, cyst wall is not thick, and calculus is changed, recovery from illness.Follow up a case by regular visits to so far, not recurrence.
Experimental example 3
Medicine composite for curing ureteral calculus 16 examples of the present invention obtain remarkable result, now are reported as follows:
1, clinical data
Pharmaceutical composition clinical observation ureteral calculus patient 16 examples of the present invention, male's 12 examples, women's 4 examples; Age 16-50 year 11 examples, 5 examples more than 50 years old.
2, diagnostic criteria
16 routine patients all confirm to suffer from ureteral calculus through ultrasound diagnosis.
3, Therapeutic Method
3.1 medicine is formed: Herba Lysimachiae 13g, Radix Clematidis 13g, Cornu Bovis seu Bubali silk 13g, Endothelium Corneum Gigeriae Galli 4g, Folium Pyrrosiae 5g, Talcum 8g, Mirabilitum 4g, Pumex 6g, HUOXUEDAN 13g, Asteriscus Pseudosciaenae 4g, Semen Abutili 8g, Sal Nitri 4g, Semen Plantaginis 4g, Spora Lygodii 5g, Poria 4g, Flos Lonicerae 4g, Herba Taraxaci 8g, Radix Et Rhizoma Rhei 1.5g Radix Notoginseng 4g, Rhizoma Corydalis 4g, Herba Artemisiae Scopariae 8g, Radix Curcumae 4g, Herba Camptosori Sibirici 8g, Hirudo 1g, Tabanus 1g, Herba Polygoni Avicularis 4g, Herba Dianthi 4g, Rhizoma Coptidis 3g, Herba clerodendranthi spicati 8g, Radix Salviae Miltiorrhizae 5g.
3.2 instructions of taking: said medicine technology is routinely made powder, every day 3 times, each 18 grams.
4, treatment standard
Recovery from illness: confirm not see calculus through ultrasound diagnosis;
Take a turn for the better: calculus part contracted position moves down;
Invalid: with indistinction before the treatment.
5, therapeutic outcome
16 routine patients there is no calculus through ultrasound diagnosis, and treatment time is the shortest 4 days, and are the longest 30 days, and cure rate is 100%.
Experimental example 4
Medicine composite for curing choledocholithiasis 13 examples of the present invention obtain remarkable result, now are reported as follows:
1, clinical data
Pharmaceutical composition clinical observation patients with choledocholith 13 examples of the present invention, male's 8 examples, women's 5 examples; Age 16-50 year 7 examples, 6 examples more than 50 years old.
2, diagnostic criteria
16 routine patients all confirm to suffer from choledocholithiasis through ultrasound diagnosis.
3, Therapeutic Method
3.1 medicine is formed: Herba Lysimachiae 13g, Radix Clematidis 13g, Cornu Bovis seu Bubali silk 13g, Endothelium Corneum Gigeriae Galli 4g, Folium Pyrrosiae 5g, Talcum 8g, Mirabilitum 4g, Pumex 6g, HUOXUEDAN 13g, Asteriscus Pseudosciaenae 4g, Semen Abutili 8g, Sal Nitri 4g, Semen Plantaginis 4g, Spora Lygodii 5g, Poria 4g, Flos Lonicerae 4g, Herba Taraxaci 8g, Radix Et Rhizoma Rhei 1.5g Radix Notoginseng 4g, Rhizoma Corydalis 4g, Herba Artemisiae Scopariae 8g, Radix Curcumae 4g, Herba Camptosori Sibirici 8g, Hirudo 1 g, Tabanus 1g, Herba Polygoni Avicularis 4g, Herba Dianthi 4g, Rhizoma Coptidis 3g, Herba clerodendranthi spicati 8g, Radix Salviae Miltiorrhizae 5g.
3.2 instructions of taking: said medicine technology is routinely made decoction, per two days potions.
4, treatment standard
Recovery from illness: confirm not see calculus through ultrasound diagnosis;
Take a turn for the better: calculus part contracted position moves down;
Invalid: with indistinction before the treatment.
5, therapeutic outcome
13 routine patients there is no calculus through ultrasound diagnosis, and treatment time is the shortest 6 days, and are the longest 25 days, and cure rate is 100%.
Following embodiment all can realize the effect of above-mentioned experimental example.
The specific embodiment
Embodiment 1:
Herba Lysimachiae 13kg Radix Clematidis 13kg Cornu Bovis seu Bubali silk 13kg Endothelium Corneum Gigeriae Galli 4kg
Folium Pyrrosiae 5kg Talcum 8kg Mirabilitum 4kg Pumex 6kg
HUOXUEDAN 13kg Asteriscus Pseudosciaenae 4kg Semen Abutili 8kg Sal Nitri 4kg
Semen Plantaginis 4kg Spora Lygodii 5kg Poria 4kg Flos Lonicerae 4kg
Herba Taraxaci 8kg Radix Et Rhizoma Rhei 1.5kg Radix Notoginseng 4kg Rhizoma Corydalis 4kg
Herba Artemisiae Scopariae 8kg Radix Curcumae 4kg Herba Camptosori Sibirici 8kg Hirudo 1kg
Tabanus 1kg Herba Polygoni Avicularis 4kg Herba Dianthi 4kg Rhizoma Coptidis 3kg
Herba clerodendranthi spicati 8kg Radix Salviae Miltiorrhizae 5kg
Said medicine technology is routinely made decoction, two days potions.
Embodiment 2:
Herba Lysimachiae 8kg Radix Clematidis 18kg Cornu Bovis seu Bubali silk 8kg
Endothelium Corneum Gigeriae Galli 5kg Folium Pyrrosiae 3kg Talcum 10kg
Mirabilitum 3kg Pumex 8kg HUOXUEDAN 8kg
Asteriscus Pseudosciaenae 5kg Semen Abutili 6kg Sal Nitri 5kg
Semen Plantaginis 3kg Spora Lygodii 6kg Poria 3kg
Flos Lonicerae 5kg Herba Taraxaci 6kg Radix Et Rhizoma Rhei 1.8kg
Radix Notoginseng 3kg Rhizoma Corydalis 5kg Herba Artemisiae Scopariae 6kg
Radix Curcumae 5kg Herba Camptosori Sibirici 6kg Hirudo 1.2kg
Tabanus 0.7kg Herba Polygoni Avicularis 5kg Herba Dianthi 3kg
Rhizoma Coptidis 4kg Herba clerodendranthi spicati 10kg Radix Salviae Miltiorrhizae 3kg
Said medicine technology routinely adds conventional adjuvant and makes powder, every day three times, each 18 grams.
Embodiment 3:
Herba Lysimachiae 18kg Radix Clematidis 8kg Cornu Bovis seu Bubali silk 18kg
Endothelium Corneum Gigeriae Galli 3kg Folium Pyrrosiae 7kg Talcum 6kg
Mirabilitum 5kg Pumex 4kg HUOXUEDAN 18kg
Asteriscus Pseudosciaenae 3kg Semen Abutili 10kg Sal Nitri 3kg
Semen Plantaginis 5kg Spora Lygodii 3kg Poria 5kg
Flos Lonicerae 3kg Herba Taraxaci 10kg Radix Et Rhizoma Rhei 1.2kg
Radix Notoginseng 5kg Rhizoma Corydalis 3kg Herba Artemisiae Scopariae 10kg
Radix Curcumae 3kg Herba Camptosori Sibirici 10kg Hirudo 0.7kg
Tabanus 1.2kg Herba Polygoni Avicularis 3kg Herba Dianthi 5kg
Rhizoma Coptidis 2kg Herba clerodendranthi spicati 10kg Radix Salviae Miltiorrhizae 3kg
Said medicine technology routinely adds conventional adjuvant and makes drop pill.
Embodiment 4:
Herba Lysimachiae 13kg Radix Clematidis 13kg Cornu Bovis seu Bubali silk 13kg Endothelium Corneum Gigeriae Galli 4kg
Folium Pyrrosiae 5kg Talcum 8kg Mirabilitum 4kg Pumex 6kg
HUOXUEDAN 13kg Asteriscus Pseudosciaenae 4kg Semen Abutili 8kg Sal Nitri 4kg
Semen Plantaginis 4kg Spora Lygodii 5kg Poria 4kg Flos Lonicerae 4kg
Herba Taraxaci 8kg Radix Et Rhizoma Rhei 1.5kg Radix Notoginseng 4kg Rhizoma Corydalis 4kg
Herba Artemisiae Scopariae 8kg Radix Curcumae 4kg Herba Camptosori Sibirici 8kg Hirudo 1kg
Tabanus 1kg Herba Polygoni Avicularis 4kg Herba Dianthi 4kg Rhizoma Coptidis 3kg
Herba clerodendranthi spicati 8kg Radix Salviae Miltiorrhizae 5kg
Said medicine technology routinely adds conventional adjuvant and makes oral liquid.
Claims (8)
1. pharmaceutical composition for the treatment of calculus is characterized in that the crude drug of this pharmaceutical composition consists of:
Herba Lysimachiae 6-20 weight portion Radix Clematidis 6-20 weight portion Cornu Bovis seu Bubali silk 6-20 weight portion
Endothelium Corneum Gigeriae Galli 2-6 weight portion Folium Pyrrosiae 2-8 weight portion Talcum 4-12 weight portion
Mirabilitum 2-6 weight portion Pumex 3-9 weight portion HUOXUEDAN 6-20 weight portion
Asteriscus Pseudosciaenae 2-6 weight portion Semen Abutili 4-12 weight portion Sal Nitri 2-6 weight portion
Semen Plantaginis 2-6 weight portion Spora Lygodii 2-8 weight portion Poria 2-6 weight portion
Flos Lonicerae 2-6 weight portion Herba Taraxaci 4-12 weight portion Radix Et Rhizoma Rhei 1-2 weight portion
Radix Notoginseng 2-6 weight portion Rhizoma Corydalis 2-6 weight portion Herba Artemisiae Scopariae 4-12 weight portion
Radix Curcumae 2-6 weight portion Herba Camptosori Sibirici 4-12 weight portion Hirudo 0.5-1.5 weight portion
Tabanus 0.5-1.5 weight portion Herba Polygoni Avicularis 2-6 weight portion Herba Dianthi 2-6 weight portion
Rhizoma Coptidis 1.5-4.5 weight portion Herba clerodendranthi spicati 4-12 weight portion Radix Salviae Miltiorrhizae 2-8 weight portion.
2. pharmaceutical composition according to claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
Herba Lysimachiae 13 weight portion Radix Clematidis 13 weight portion Cornu Bovis seu Bubali silk 13 weight portions
Endothelium Corneum Gigeriae Galli 4 weight portion Folium Pyrrosiae 5 weight portion Talcums 8 weight portions
Mirabilitum 4 weight portion Pumexs 6 weight portion HUOXUEDAN 13 weight portions
Asteriscus Pseudosciaenae 4 weight portion Semen Abutilis 8 weight portion Sal Nitri 4 weight portions
Semen Plantaginis 4 weight portion Spora Lygodii 5 weight portion Porias 4 weight portions
Flos Lonicerae 4 weight portion Herba Taraxacis 8 weight portion Radix Et Rhizoma Rhei 1.5 weight portions
Radix Notoginseng 4 weight portion Rhizoma Corydalis 4 weight portion Herba Artemisiae Scopariaes 8 weight portions
Radix Curcumae 4 weight portion Herba Camptosori Sibiricis 8 weight portion Hirudos 1 weight portion
Tabanus 1 weight portion Herba Polygoni Avicularis 4 weight portion Herba Dianthis 4 weight portions
Rhizoma Coptidis 3 weight portion Herba clerodendranthi spicati 8 weight portion Radix Salviae Miltiorrhizaes 5 weight portions.
3. pharmaceutical composition according to claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
Herba Lysimachiae 8 weight portion Radix Clematidis 18 weight portion Cornu Bovis seu Bubali silk 8 weight portions
Endothelium Corneum Gigeriae Galli 5 weight portion Folium Pyrrosiae 3 weight portion Talcums 10 weight portions
Mirabilitum 3 weight portion Pumexs 8 weight portion HUOXUEDAN 8 weight portions
Asteriscus Pseudosciaenae 5 weight portion Semen Abutilis 6 weight portion Sal Nitri 5 weight portions
Semen Plantaginis 3 weight portion Spora Lygodii 6 weight portion Porias 3 weight portions
Flos Lonicerae 5 weight portion Herba Taraxacis 6 weight portion Radix Et Rhizoma Rhei 1.8 weight portions
Radix Notoginseng 3 weight portion Rhizoma Corydalis 5 weight portion Herba Artemisiae Scopariaes 6 weight portions
Radix Curcumae 5 weight portion Herba Camptosori Sibiricis 6 weight portion Hirudos 1.2 weight portions
Tabanus 0.7 weight portion Herba Polygoni Avicularis 5 weight portion Herba Dianthis 3 weight portions
Rhizoma Coptidis 4 weight portion Herba clerodendranthi spicati 10 weight portion Radix Salviae Miltiorrhizaes 3 weight portions.
4. pharmaceutical composition according to claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
Herba Lysimachiae 18 weight portion Radix Clematidis 8 weight portion Cornu Bovis seu Bubali silk 18 weight portions
Endothelium Corneum Gigeriae Galli 3 weight portion Folium Pyrrosiae 7 weight portion Talcums 6 weight portions
Mirabilitum 5 weight portion Pumexs 4 weight portion HUOXUEDAN 18 weight portions
Asteriscus Pseudosciaenae 3 weight portion Semen Abutilis 10 weight portion Sal Nitri 3 weight portions
Semen Plantaginis 5 weight portion Spora Lygodii 3 weight portion Porias 5 weight portions
Flos Lonicerae 3 weight portion Herba Taraxacis 10 weight portion Radix Et Rhizoma Rhei 1.2 weight portions
Radix Notoginseng 5 weight portion Rhizoma Corydalis 3 weight portion Herba Artemisiae Scopariaes 10 weight portions
Radix Curcumae 3 weight portion Herba Camptosori Sibiricis 10 weight portion Hirudos 0.7 weight portion
Tabanus 1.2 weight portion Herba Polygoni Avicularis 3 weight portion Herba Dianthis 5 weight portions
Rhizoma Coptidis 2 weight portion Herba clerodendranthi spicati 10 weight portion Radix Salviae Miltiorrhizaes 3 weight portions.
5. according to the described pharmaceutical composition of one of claim 1-4, it is characterized in that this pharmaceutical composition adds the dosage form that conventional adjuvant is made clinical acceptance by practice of pharmacy.
6. pharmaceutical composition according to claim 5 is characterized in that described dosage form is tablet, capsule, granule, pill, powder, decoction, oral liquid, lyophilized powder or drop pill.
7. according to the application of the described pharmaceutical composition of one of claim 1-4 in preparation treatment calculus medicine.
8. the application of pharmaceutical composition according to claim 7 is characterized in that described calculus is renal calculus, ureteral calculus, cholelithiasis or choledocholithiasis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101124798A CN101199818B (en) | 2007-06-28 | 2007-06-28 | Medicament compound for treating calculus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101124798A CN101199818B (en) | 2007-06-28 | 2007-06-28 | Medicament compound for treating calculus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101199818A true CN101199818A (en) | 2008-06-18 |
| CN101199818B CN101199818B (en) | 2010-06-02 |
Family
ID=39515302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007101124798A Expired - Fee Related CN101199818B (en) | 2007-06-28 | 2007-06-28 | Medicament compound for treating calculus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101199818B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101579507B (en) * | 2009-03-23 | 2011-06-15 | 路正平 | Medicine for treating gall stones and preparation method thereof |
| CN102824483A (en) * | 2012-07-28 | 2012-12-19 | 洪侠 | Traditional Chinese medicine for Qi stagnation and blood stasis type kidney stone |
| CN105193955A (en) * | 2015-10-30 | 2015-12-30 | 李少波 | Traditional Chinese medicine composition for treating gallstone |
| CN106215117A (en) * | 2016-08-25 | 2016-12-14 | 谭曜 | A kind of Chinese medicine composition treating cholelithiasis |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103110765B (en) * | 2013-02-18 | 2014-05-21 | 于浩 | Traditional Chinese medicine for treating renal calculi |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1241411A (en) * | 1998-07-10 | 2000-01-19 | 任德贵 | Pain-relieving stone-dissolving powder (bolus) |
| CN1269520C (en) * | 2003-06-05 | 2006-08-16 | 黄山 | Medicine for treating human lithic disease |
-
2007
- 2007-06-28 CN CN2007101124798A patent/CN101199818B/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101579507B (en) * | 2009-03-23 | 2011-06-15 | 路正平 | Medicine for treating gall stones and preparation method thereof |
| CN102824483A (en) * | 2012-07-28 | 2012-12-19 | 洪侠 | Traditional Chinese medicine for Qi stagnation and blood stasis type kidney stone |
| CN105193955A (en) * | 2015-10-30 | 2015-12-30 | 李少波 | Traditional Chinese medicine composition for treating gallstone |
| CN106215117A (en) * | 2016-08-25 | 2016-12-14 | 谭曜 | A kind of Chinese medicine composition treating cholelithiasis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101199818B (en) | 2010-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101199818B (en) | Medicament compound for treating calculus | |
| CN102813791B (en) | Traditional Chinese medicine composition for treating kidney stone | |
| CN111388582B (en) | Traditional Chinese medicine composition for treating novel coronavirus pneumonia and application of preparation thereof | |
| CN102847073A (en) | Medicine for promoting discharging of urinary calculus | |
| CN1130219C (en) | Litholysizing bear gall powder | |
| CN103341057B (en) | Chinese patent medicine pill for treating calculus, nephritis and cholecystitis | |
| CN104173782A (en) | Medicine treating urinary calculi | |
| CN101822804B (en) | Medicament for treating urinary system calculus and preparation method thereof | |
| CN104491459A (en) | Traditional Chinese medicine composition for treating tumors | |
| CN101181344B (en) | Chinese medicine medicament for curing renal calculs | |
| CN100340284C (en) | Jindan gallbladder stone dissolving capsule | |
| CN103610932B (en) | Medicament for treating urinary calculus | |
| CN1480203A (en) | Preparation of Chinese herbal medicine to be taken after being mixed with boiling water for removal of urinary calculus | |
| CN103432506B (en) | Pharmaceutical composition for treating upper respiratory infection | |
| CN1083271C (en) | Drug for curing stone of urinary system | |
| CN104474184B (en) | A kind of drug for treating cough after common cold | |
| CN102475777A (en) | Urolith elimination | |
| CN103830646B (en) | A kind of preparation method of the pharmaceutical composition treating kidney or ureter stone | |
| CN1539448A (en) | Medicine for treating rheumatic and rheumatoid arthritis | |
| CN101810790A (en) | Chinese medicinal preparation for curing ureteral calculi | |
| CN101185719B (en) | Medicinal composition for treating rhinitis and nasosinusitis | |
| CN101590194A (en) | Traditional Chinese medicine for treating urinary calculus | |
| CN109453283A (en) | Numbness leads to soup and application thereof | |
| CN1168472C (en) | Chinese medicine prepn for treating lupus erythematosus | |
| CN1101208C (en) | Medicine for treating uninary calculaus and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100602 Termination date: 20120628 |